K2 Asset Management’s Stephen Scott on three companies he favours for 2021
Stephen Scott leads K2 Asset Management’s Annapurna Microcap Fund alongside fellow Contango microcap alumni Bill Laister.
News
AstraZeneca
News
The view from K2: Stephen Scott shares three companies he favours
Side-effects caused by the AstraZeneca COVID-19 vaccine have created a detour on Australia’s road to recovery, but K2
News
‘Vaccine Mondays’: Short term gold pain unlikely to hurt long-term gains
Gold prices are still tipped to rise, despite suffering a sizeable fall after pharmaceutical giant AstraZeneca published promising